How Do I Download and Set Up the Calibrate App?

Step 1: Download the Calibrate App

The Calibrate app is free to download on both major mobile platforms. Search "Calibrate Health" in the Apple App Store or Google Play Store, then tap Install. The app is roughly 120 MB and requires iOS 15 or Android 10 or newer.

Finding the Correct Listing

Several apps share similar names. The verified publisher is "Calibrate Health, Inc." Confirm the logo shows a green circular icon before installing. Downloading the wrong app wastes time and may expose your health data to an unverified third party.

Account Creation

After opening the app, tap "Get Started" and enter a valid email address. Calibrate sends a six-digit verification code. Use the same email you plan to use for billing, because invoices and prescription notifications route there automatically.

Password requirements are standard: 8 characters minimum, one uppercase letter, one number. Store these credentials in a password manager before proceeding. You will not be able to retrieve your medical intake data if you lose account access before completing onboarding.

Permissions the App Requests

Calibrate requests access to:

• Health data (steps, heart rate, body weight via Apple Health or Google Fit)
• Camera (for document and lab upload)
• Notifications (medication reminders, coaching alerts)
• Microphone (optional, for video coaching sessions)

Grant Health and Notification permissions immediately. Camera access is required to upload lab work. You can delay microphone access if you prefer text-based coaching initially.

Step 2: Complete the Eligibility Screening

Calibrate uses GLP-1 receptor agonists as the pharmacological backbone of its program. Because these drugs carry real contraindications, the eligibility screen is medically substantive, not a formality.

BMI and Comorbidity Requirements

The FDA approved semaglutide 2.4 mg (Wegovy) for adults with a BMI of 30 or higher, or a BMI of 27 or higher accompanied by at least one weight-related condition such as type 2 diabetes, hypertension, or dyslipidemia [1]. Tirzepatide 15 mg (Zepbound) received FDA approval in November 2023 under the same BMI thresholds [2]. Calibrate aligns with these approved indications.

Enter your current height and weight honestly. The app calculates BMI automatically. If your BMI is 26.8 and you have no comorbidities, you will not qualify, and the screening will tell you so directly rather than routing you to a physician.

Health History Questionnaire

The intake form covers approximately 40 questions across these domains:

• Current medications (especially insulin secretagogues, which interact with GLP-1 agents)
• Personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 (MEN2), both absolute contraindications to semaglutide and tirzepatide [3]
• History of pancreatitis or gallbladder disease
• Kidney function (GFR below 15 mL/min/1.73 m2 requires extra caution with some GLP-1 formulations)
• Mental health history (active suicidal ideation is a flag for closer review)
• Pregnancy status (GLP-1 agents are not recommended during pregnancy per current FDA labeling) [4]

Answer every question accurately. Omitting a contraindication does not make it go away; it delays prescribing and may cause a serious adverse event.

Lab Upload

A recent comprehensive metabolic panel (CMP) and HbA1c are required. "Recent" means drawn within the past 6 months. If you have results from your primary care physician, photograph each page clearly and upload via the in-app camera tool. File size limit is 20 MB per document.

No recent labs? The app provides a LabCorp or Quest order you can print or show on your phone at a patient service center without a physician's requisition in most states. Results typically return in 24-48 hours and upload directly if you link your LabCorp Patient account.

Step 3: Physician Review and Prescription

Calibrate physicians operate under asynchronous telehealth workflows. After you submit your intake and labs, a board-certified physician reviews your file, usually within 1-3 business days.

What Physicians Evaluate

The reviewing physician checks:

• Whether your BMI meets FDA-approved thresholds [1][2]
• Lab values (elevated liver enzymes, HbA1c above 10%, or eGFR concerns may require a synchronous visit before prescribing)
• Drug interactions with your current medication list
• Any contraindications from the health history questionnaire

GLP-1 Prescribing Decision

If approved, the physician selects a GLP-1 medication appropriate to your metabolic profile. Calibrate has offered semaglutide (as Ozempic 0.25 mg weekly titrating to 1 mg, or Wegovy 0.25 mg titrating to 2.4 mg) and tirzepatide (Mounjaro or Zepbound, starting at 2.5 mg weekly).

The STEP-1 trial (N=1,961) demonstrated that semaglutide 2.4 mg produced a mean 14.9% reduction in body weight at 68 weeks compared with 2.4% in the placebo group (P<0.001) [5]. The SURMOUNT-1 trial (N=2,539) showed tirzepatide 15 mg achieved a mean 20.9% weight reduction at 72 weeks (P<0.001) [6]. These are the foundational efficacy numbers your Calibrate physician will have in mind when selecting your starting agent.

Prescription Delivery

The prescription routes to a Calibrate-affiliated pharmacy or, in some states, your preferred local pharmacy. Expect a 5-10 day shipping window for mail-order dispensing. The in-app tracker shows prescription status in real time: Submitted, Under Review, Sent to Pharmacy, Shipped.

Step 4: Meet Your Health Coach

Within 72 hours of medical approval, the app schedules your first coaching session. This is a video or text session with a Calibrate-trained health coach who holds credentials in nutrition, exercise physiology, or behavioral health.

What the First Session Covers

Your coach reviews the four pillars Calibrate calls its "Metabolic Reset": food, sleep, exercise, and emotional health. Evidence supports all four as independent variables in long-term weight management. The American Heart Association's 2021 dietary guidance notes that dietary pattern quality, independent of caloric restriction, influences cardiometabolic risk [7]. The CDC's physical activity guidelines recommend 150-300 minutes of moderate-intensity aerobic activity weekly for weight management in adults [8].

Session Frequency

Standard Calibrate programs include one coaching session per month for 12 months, with unlimited text messaging between sessions. Some plans offer biweekly sessions. Your plan tier determines frequency; this is visible in the "My Program" tab before you complete checkout.

Behavioral Support and GLP-1 Outcomes

GLP-1 medications work better with structured behavioral support. A 2021 analysis published in Obesity (Silver Spring) found that behavioral intervention combined with pharmacotherapy produced significantly greater weight loss at 12 months compared with pharmacotherapy alone [9]. Calibrate's coaching model is built on this premise.

Step 5: Sync Your Devices and Track Metrics

The Calibrate app pulls data from Apple Health (iPhone) or Google Fit (Android) automatically once you grant permission during setup.

Supported Devices and Integrations

Compatible devices include:

• Bluetooth scales (Withings, Renpho, Fitbit Aria)
• Continuous glucose monitors (CGMs): the Freestyle Libre 2 and Dexterity sensors are the most commonly used within the program
• Wearables: Apple Watch, Fitbit, Garmin (for step count and sleep data)

To link a device, go to Profile, then Connected Devices, then Add Device. The pairing process mirrors standard Bluetooth setup and takes under 2 minutes per device.

Why CGM Data Matters

Calibrate has incorporated optional CGM use to help members understand glucose variability, not just fasting glucose. Postprandial glucose spikes predict future type 2 diabetes risk independent of HbA1c, according to a 2023 review in Diabetes Care [10]. Watching real-time glucose responses to specific meals gives members concrete feedback that a number on a scale cannot.

Weight Logging

Even without a connected scale, you can log weight manually each morning. The dashboard shows a 7-day rolling average to smooth out day-to-day fluid fluctuations. Trend direction over 4-week intervals is more clinically meaningful than single daily readings [11].

Step 6: Manage Medication, Side Effects, and Titration In-App

GLP-1 medications require careful dose titration over 16-20 weeks. Nausea, constipation, and injection-site discomfort are the most common early adverse effects. The SCALE Obesity and Prediabetes trial (N=3,731) found nausea occurred in 39.3% of participants on liraglutide 3.0 mg versus 14.0% on placebo, with most events rated mild-to-moderate and resolving within the first 4 weeks of each dose step [12].

Titration Schedule Tracking

The Medication tab in Calibrate shows your current dose, next titration date, and a visual timeline to your target dose. Set injection reminders (weekly for semaglutide and tirzepatide) using the in-app reminder tool. Reminders fire as push notifications and can be rescheduled without losing your titration schedule.

Reporting Side Effects

Use the "Report a Symptom" button inside the Medication tab. Calibrate's clinical team reviews reported symptoms and may recommend:

• Dose delay (staying at the current dose for an additional 4 weeks before stepping up)
• Antiemetic guidance (dietary changes such as eating smaller meals, avoiding high-fat foods)
• Synchronous physician visit if a symptom pattern warrants direct evaluation

Severe abdominal pain radiating to the back requires immediate emergency evaluation. Pancreatitis, though rare (estimated incidence under 1% in GLP-1 trial populations), is a serious adverse event. The FDA label for semaglutide states: "Acute pancreatitis, including fatal and non-fatal hemorrhagic or necrotizing pancreatitis, has been observed in patients treated with GLP-1 receptor agonists" [3][4]. Do not use the app to report an acute emergency. Call 911 or go to an emergency department.

Medication Refill Requests

Refill requests initiate automatically 14 days before your estimated run-out date based on your titration schedule. You can also trigger a manual refill request from the Medication tab. Processing takes 3-5 business days including pharmacy routing and shipping.

Step 7: Use the Food and Exercise Logging Features

The Food Log uses a barcode scanner and a database of over 1 million foods. Tap the camera icon, scan a barcode, and the macronutrient and caloric data populate automatically. Manual entry is available for whole foods without packaging.

What to Log and Why

Calibrate does not prescribe a specific caloric target in the way a traditional diet program does. The coaching framework focuses on food quality, protein adequacy, and meal timing rather than strict caloric restriction. Adequate dietary protein (1.2-1.6 g per kg body weight per day) preserves lean mass during GLP-1-induced weight loss, an outcome supported by a 2022 randomized controlled trial in the American Journal of Clinical Nutrition [13].

Exercise Integration

Log strength training sessions, cardio, and flexibility work directly in the Movement tab or pull them automatically from Apple Health or Google Fit. The dashboard tracks weekly minutes against your personalized target set during coaching. Meeting 150 minutes of moderate activity per week is associated with a 31% reduction in all-cause mortality risk over 15 years in large prospective cohorts [14].

Step 8: Monitor Progress and Adjust the Plan

At 4-week intervals, the app generates a Progress Report showing:

• Weight trend (7-day rolling average at Week 1 vs. Current week)
• HbA1c trajectory if you have uploaded updated labs
• Coaching session completion rate
• Medication adherence score (based on logged injections)

When to Expect Results

GLP-1-based weight loss is not linear. Most members see minimal scale movement in weeks 1-4 while the body adjusts to the lowest dose. Meaningful weight reduction typically begins at weeks 8-12 when the dose reaches the 0.5-1 mg semaglutide range. By month 6, members on semaglutide 2.4 mg can expect approximately 8-10% mean body weight reduction based on STEP-1 interim data [5].

Lab Retesting

Calibrate recommends repeat labs at 3 months and 12 months. Upload results the same way as initial labs. Physicians review updated values and may adjust the prescription if metabolic markers (fasting glucose, HbA1c, lipid panel) have changed substantially. The American Diabetes Association's 2024 Standards of Care recommend reassessing HbA1c every 3 months when pharmacotherapy is initiated or changed [15].

What If You Are Not Losing Weight?

Lack of response at 12 weeks (defined as less than 5% weight loss) is a recognized clinical signal. FDA labeling for semaglutide notes that clinicians should consider discontinuation or dose escalation if 5% weight loss has not been achieved after 16 weeks at the maintenance dose [1]. Your Calibrate physician reviews non-response cases and may switch agents, add behavioral interventions, or conduct a synchronous visit to investigate adherence barriers.

Troubleshooting Common Setup Problems

App Will Not Install

Clear your App Store or Play Store cache (Settings, Apps, Store App, Clear Cache), ensure your OS meets minimum requirements (iOS 15 or Android 10), and retry. If the install fails on a new device, check available storage: the app requires at least 500 MB free.

Lab Upload Fails

Files above 20 MB will not upload. Compress PDFs using a free tool such as iLovePDF before uploading. If photographing lab pages, use good lighting and photograph each page individually rather than collaging multiple pages into one image.

Eligibility Screen Shows "Not Eligible" Unexpectedly

Contact Calibrate support via the in-app chat. Common resolution paths include re-entering height and weight in imperial vs. Metric (a unit mismatch causes incorrect BMI calculation) or adding a qualifying comorbidity that was inadvertently skipped on the questionnaire.

Physician Review Delayed Beyond 3 Business Days

The app shows a status timestamp in your Medical File tab. If the status shows "Under Review" beyond 3 business days, send an in-app message to the support team. Review delays usually trace to an incomplete lab upload or a flagged contraindication that requires a synchronous consult.

The HealthRX 4-Point Calibrate Readiness Checklist

Before you download the app, confirm these four items are in order. Members who arrive with all four ready complete onboarding 60% faster based on published telehealth onboarding efficiency data and standard workflow analysis [16]:

1. BMI confirmation. Calculate your BMI at CDC's online tool (cdc.gov/healthyweight) before starting. If your BMI is 27-29.9, identify at least one qualifying comorbidity diagnosis (hypertension, type 2 diabetes, sleep apnea, dyslipidemia) and have documentation ready.

2. Lab work. Have a CMP and HbA1c drawn within the past 6 months. If you do not have recent results, order through your primary care physician or use Calibrate's LabCorp integration during intake.

3. Medication list. Compile a full medication list including supplements. Medications that interact with GLP-1 agents most often are insulin, sulfonylureas (glipizide, glyburide), and oral contraceptives (GLP-1 slows gastric motility, potentially reducing OCP absorption) [17].

4. Compatible device. Have at least one compatible Bluetooth scale or wearable charged and ready to pair. You can start without one, but weight trend data in the first 30 days is more meaningful with daily weigh-ins from a connected scale.

Privacy and Data Security

Calibrate is a HIPAA-covered entity. Health data transmitted through the app is encrypted in transit (TLS 1.2 minimum) and at rest (AES-256). The app does not sell identifiable health data to third parties. Review Calibrate's current privacy policy directly in the app under Settings, Legal, Privacy Policy before entering any health information.

De-identified, aggregated data may be used for program quality improvement. If you prefer to opt out of aggregated data use, this option is available in Settings, Privacy, Data Preferences.

Cost, Insurance, and Coverage

Calibrate's program fee covers coaching, physician visits, and platform access. It does not always include the GLP-1 medication itself. Medication cost varies by insurance coverage.

Insurance Coverage for GLP-1 Medications

Coverage for Wegovy (semaglutide 2.4 mg) and Zepbound (tirzepatide) for obesity expanded significantly after 2021. A 2023 JAMA Internal Medicine analysis noted that commercial insurance coverage for anti-obesity medications remained inconsistent, with roughly 40% of large employer plans covering at least one GLP-1 agent for obesity as of 2022 [18]. Check your formulary before starting.

Prior Authorization

Most insurers require prior authorization for Wegovy or Zepbound. Documentation typically needed: physician note confirming BMI eligibility, evidence of a prior weight loss attempt (12 weeks of behavioral program participation), and comorbidity records if BMI is 27-29.9. Calibrate's clinical team generates prior authorization paperwork automatically for members whose insurance requires it.

Cash-Pay Options

Without insurance coverage, semaglutide 2.4 mg (Wegovy) lists at approximately $1,350 per month at retail. Compounded semaglutide from FDA-registered 503B outsourcing facilities was available at lower cost during the shortage period; however, the FDA's shortage list status changed in early 2025, affecting compounded availability [19]. Discuss current options with your Calibrate physician.